Mereo BioPharma Group plc held its 2026 AGM on May 14, 2026, where all resolutions passed as proposed, including auditor re-appointment, director re-elections, and share allotment authorities.
Key takeaways
All 11 resolutions passed as proposed at the 2026 AGM with 436,766,255 ordinary shares represented.
Resolutions 1-3 on accounts, auditors, and remuneration received 98%+ approval.
Resolutions 4-6 on remuneration report, policy, and executive compensation approved at 91-93%.
Directors Justin Roberts, Dr. Daniel Shames, and Marc Yoskowitz re-elected with 93-94% support.
Resolutions 10-11 on share allotment authorities passed with 80.5% approval despite 19% opposition.